dr. wolchok on the safety profile in checkmate-067 in melanoma
Published 7 years ago • 195 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
2:31
dr. wolchok on updated checkmate-067 results for melanoma
-
2:08
dr. wolchock on phase iii checkmate-067 findings
-
0:47
dr. wolchok on weighing risk and benefit of nivolumab/ipilimumab combo in melanoma
-
2:48
checkmate067 outcomes: nivolumab plus ipilimumab in advanced melanoma
-
2:02
dr. jedd wolchok on concurrent ipilimumab and nivolumab in advanced melanoma
-
1:03
dr. wolchok on remaining questions regarding immunotherapies in melanoma
-
1:38
dr. wolchok on next steps for patients with melanoma who fail on pd-1 monotherapy
-
2:05
dr. shoushtari on the design of the checkmate-067 trial in advanced melanoma
-
2:45
dr. wolchok on ipilimumab after complete resection of stage iii melanoma
-
0:59
checkmate 067: phase 3 trial of nivolumab in melanoma
-
1:42
dr. agarwala on the significance of os and toxicity results in checkmate-067
-
1:44
dr. jedd wolchok talks about a recent trial and its effects on untreated melanoma patients
-
47:41
treating melanoma with immunotherapy, with jedd wolchok
-
1:26
metastatic melanoma: the checkmate 067 and 069 trials
-
1:56
checkmate 067: combined nivolumab and ipilimumab or monotherapy in untreated melanoma
-
0:45
dr. wolchok explains the future of ipilimumab
-
2:31
checkmate-069: spectacular results with combination therapy
-
1:28
dr. wolchok on an updated analysis of pembrolizumab (mk-3475) for melanoma
-
3:47
phase 3 checkmate 067 trial of nivolumab in untreated advanced melanoma